《大行報告》法巴下調中芯(00981.HK)合理值至14.3元 評級「減持」
法巴發表報告表示,下調中芯國際(00981.HK)每股合理值至14.3元,以反映美國對中芯出口部分設備、配件及原物料的進一步限制,該合理值相當於其2021年預測市帳率為1倍。
該行預期,中芯未來五年收入及盈利年複合增長率分別為7%及10%,認為即使中芯基本面不樂觀,但該股的交易價格可能會繼續高於該行公平值估計,主因該行對短期利好因素(如額外的代工具體扶持政策等),看得要比市場更為保守。維持對中芯「減持」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.